| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-05 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0004 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0004 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0004 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |